Abstract
Cell Engineering Cell therapy is a promising approach for treating diabetes. Yin et al. developed an elegant control system by engineering cells to respond to protocatechuic acid, a metabolite in green tea. Orally ingested protocatechuic acid regulated blood glucose by triggering secretion of insulin or a short variant of human glucagon–like peptide 1 from engineered cells implanted in mouse and nonhuman primate models of type 1 and type 2 diabetes. This study demonstrates the versatility of synthetic biology for developing remotely controlled cell-based therapies for diabetes. Sci. Transl. Med. 11 , eaav8826 (2019).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
